Publication | Closed Access

Optimization of patient selection for EGFR-TKIs in advanced non-small cell lung cancer by combined analysis of KRAS, PIK3CA, MET, and non-sensitizing EGFR mutations

Patient SelectionMedicinePathologyCancer GenomicsBronchial NeoplasmCombined AnalysisCancer TreatmentLung CancerMolecular DiagnosticsOncologyRadiation OncologyNon-sensitizing Egfr MutationsTumor Microenvironment